Quick Takeaways
- Leanne Kelly has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $29,704.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Leanne Kelly
- Location
- Philadelphia, PA
- Summary
- The estimated net worth of Leanne Kelly is at least $29,704 dollars as of 22 Sep 2025. Leanne Kelly is the Chief Financial Officer of GRI Bio, Inc. and owns shares of GRI Bio, Inc. (GRI) stock worth about $29.7K.
- Signature
- /s/ Leanne Kelly
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Leanne Kelly and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: GRI Bio, Inc. ($29,704).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Leanne Kelly
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GRI | GRI Bio, Inc. | Chief Financial Officer | $29,704 | 18 Sep 2025 | ||
| WINT | WINDTREE THERAPEUTICS INC /DE/ | Director | 08 Jan 2025 |
Insider Transactions Reported by Leanne Kelly:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.